RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure

Massimiliano M. Corsi, Giorgio Leone, Alessandro Fulgenzi, Ken Wasserman, Francesco Leone, Maria Elena Ferrero

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: Procedures to diagnose renal allograft rejection depend on detection of graft dysfunction due to the presence of mononuclear leukocytic infiltrates. Design and methods: In our study, we pursued an immunodiagnostic approach utilizing an ELISA method on plasma samples to monitor patients waiting to undergo transplantation in order to evidence prognostic developments in renal transplantation and, at least, to diagnose renal chronic transplant dysfunction. We analyzed blood levels of two chemokines, RANTES and MCP-1, which are normally overexpressed locally in renal chronic rejection. Results: Our results showed that patients affected by chronic renal failure (and waiting for kidney transplant), as well as kidney-grafted patients affected by chronic transplant dysfunction, had plasma levels of RANTES significantly higher than those of controls (patients without acute or chronic pathologies). Conclusions: Our data suggest a simple method to evaluate the plasmatic presence of RANTES, which could be involved in long- term kidney graft failure.

Original languageEnglish
Pages (from-to)455-460
Number of pages6
JournalClinical Biochemistry
Volume32
Issue number6
DOIs
Publication statusPublished - Aug 1999

Keywords

  • Chronic dysfunction
  • Kidney transplantation
  • MCP-1
  • RANTES

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure'. Together they form a unique fingerprint.

Cite this